The Science

Longevity is not a promise.
It is a measurement.

Ageing is now something we can quantify, monitor, and change. The published science has moved from preventing early death to extending healthspan and supporting healthier biological ageing — read through the same twelve hallmarks, epigenetic clocks, and organ-level phenotyping that Clinic82 practises every day.

Pillar I Disease
Pillar II Lifespan
Pillar III Healthspan

The big picture

We added thirty years to human life.
Now we decide how to spend them.

Global life expectancy rose from roughly 47 years in 1900 to 73.6 in 2022. But quantity is not quality — the average person now spends nearly a decade in poor health. The frontier has shifted from preventing early death to extending healthspan and supporting healthier biological ageing.

81 yrs
UK life expectancy (ONS 2022–24)
20 yrs
UK sickspan gap (ONS 2022–24)
12
Hallmarks of ageing now mapped
82
Organ types mapped across 12 clinical domains
1900
Public health era
Life expectancy roughly 47 years. Infectious disease still the dominant killer.
1950
Vaccines and antibiotics
1990
Genomics begins
2013
Epigenetic clocks
Biological age becomes measurable in a research lab.
2026
Ageing as a modifiable condition
Frontier clinics — Clinic82 among them — read biological age at the organ level and intervene systematically.

Sources · ONS Healthy Life Expectancy, UK, 2022–2024 · Health Foundation, April 2026 · IHME Global Burden of Disease 2024 · Columbia Mailman, Public Health 4.0 2025.

Measuring ageing

You have two ages.
One may be more modifiable.

Chronological age is a poor predictor of how you will age. Biological age — read through epigenetic clocks, plasma proteomics and metabolic markers — is more accurate and, critically, modifiable.

1835–1923

Early measures

Physiological markers

Grip strength, spirometry (“vital capacity”) and VO₂ max — the first tools to quantify how the body ages.1

1976 – date

Disease predictors

Event-based risk

Framingham, Gail Model, CHA₂DS₂-VASc, QRISK and SCORE — event-based risk algorithms for heart disease, breast cancer and stroke.2

2006 – date

Lifespan predictors

Prediction only

Lifespan/disease-prediction tests offer lifespan prediction, but are limited as they are unable to measure actual biological ageing in the body well.3

2026

Zolman Clocks

Organ-type mapping

Imaging, device and biosample markers that change with age, measured across the 82 organ types and combined with existing disease and lifespan predictors.4

1 Grip strength (Adolphe Quetelet, 1835); spirometry (John Hutchinson, 1846); VO₂ max (Archibald Hill, 1923).

2 Framingham risk score (1976) for heart disease; Gail Model (1989) for breast cancer; CHA₂DS₂-VASc (2010) for stroke risk; QRISK1–3 and SCORE for heart disease.

3 Lee-Schonberg Index, Life Insurance Tables, Suemoto Index, Horvath’s Clock, GrimAge, LinAge2, Levine PhenoAge blood panel.

4 Zolman Clocks methodology developed with Dr Oliver Zolman.

Sources · Quetelet 1835 · Hutchinson 1846 · Hill 1923 · Framingham Heart Study 1976 · Gail et al., JNCI 1989 · Lip et al., Chest 2010 (CHA₂DS₂-VASc) · Hippisley-Cox et al., BMJ 2017 (QRISK3) · Horvath, Genome Biology 2013 · Levine et al., Aging 2018 (PhenoAge) · Lu et al., Aging 2019 (GrimAge) · Fong et al., npj Aging 2025 (LinAge2).

Pillar I · Disease

Why we age: the twelve hallmarks.

López-Otín et al. (Cell, 2023) mapped twelve molecular root causes of ageing. They are interconnected — chronic inflammation links all twelve — so targeting one cascade can slow many at once.

01
Genomic instabilityPrimary
02
Telomere attritionPrimary
03
Epigenetic alterationsPrimary
04
Loss of proteostasisPrimary
05
Disabled autophagyAntagonistic
06
Deregulated nutrient-sensingAntagonistic
07
Mitochondrial dysfunctionAntagonistic
08
Cellular senescenceAntagonistic
09
Stem cell exhaustionIntegrative
10
Altered intercellular communicationIntegrative
11
Chronic inflammationIntegrative
12
Gut dysbiosisIntegrative

Sources · López-Otín et al., Cell 2023 · Nature, Immunosenescence and Inflammaging 2025.

Pillar II · Lifespan

How long can we live?

The documented maximum is 122 years. Research suggests a biological ceiling of 120–150, set by loss of physiological resilience — not any single disease. The gap between average and ceiling is mostly environmental and behavioural, not genetic.

Lifestyle & behaviour
40%
Social determinants
30%
Environment
20%
Genetics
10%

Sources · ONS Healthy Life Expectancy, UK, 2022–2024 · Health Foundation, April 2026 · Nature Aging 2024 · Institute for Health Metrics and Evaluation 2024.

Pillar III · Healthspan

More life in your years.
Not just more years.

The healthspan → lifespan → ceiling · UK figures · shared scale 0–150 years
Healthspan today
61 yrs
20 yr gap
Lifespan today
81 yrs
Documented maximum
122 yrs
Biological ceiling
~150 yrs
050100150

The documented maximum is 122 — Jeanne Calment. The biological ceiling is estimated at 120–150 years. Clinic82's work is closing the space between where we are and where we can be.

Movement

Exercise

Zone 2 cardio and resistance training can improve VO₂ max, one of the strongest predictors of long-term cardiovascular and all-cause mortality risk.

Fuel

Nutrition

Time-restricted eating, protein optimisation and Mediterranean dietary patterns are associated with reduced late-life morbidity in observational and interventional studies.

Recovery

Sleep

Seven to nine hours. Poor sleep interacts with multiple ageing hallmarks and is associated with accelerated epigenetic ageing in longitudinal cohorts.

Meaning

Purpose

Strong social connection and a sense of life purpose are associated with meaningful gains in healthy life expectancy in multiple population studies.

Sources · Garmany & Terzic, Nature Communications Medicine 2025 · Columbia Mailman 2025.

The 82-organ-type framework

Ageing does not happen
to a body. It happens organ by organ.

A person is not one system ageing at one rate. Kidneys, arteries, brain, pancreas — each has its own biological age, its own trajectory, its own set of dominant hallmarks.

The 82-organ-type framework — architected by Dr Oliver Zolman MBBS BSc, author of the Longevity Level 1–2–3 Protocol and Project Blueprint — maps the body as 82 organ types across 12 clinical domains. Each is measured, mapped against clinically relevant reference ranges and the patient’s individual trajectory, and given an intervention plan of its own. It is what makes a Clinic82 assessment more than a panel of bloods and a longevity brochure.

Ageing, addressed this way, becomes tractable — a set of local problems with local answers, not one abstract condition.

The framework maps 82 organ types across 12 clinical domains spanning male and female anatomy. Each patient is assessed across the organ types relevant to their anatomy, clinical history and individual requirements.

The 82-organ-type framework · Dr Oliver Zolman MBBS BSc · Longevity Level 1–2–3 Protocol · Project Blueprint.

The longevity circle

The minds rewriting human biology.

The clinicians and scientists defining the field — and the one Clinic82 works alongside.

DS
David Sinclair
Harvard Medical School

Information theory of ageing; partial cellular reprogramming.

EB
Elizabeth Blackburn
Nobel Laureate · UCSF

Discovered telomerase; telomere biology of ageing.

SH
Steve Horvath
UCLA · Altos Labs

Creator of the epigenetic clock and GrimAge.

NB
Nir Barzilai
Albert Einstein College

Centenarian genetics; leads the FDA TAME trial.

PA
Peter Attia
Physician · "Outlive"

Defines Medicine 3.0 — ageing as the root disease.

VL
Valter Longo
USC Longevity Institute

Fasting-mimicking diet; autophagy and stem-cell renewal.

OZ
Dr Oliver Zolman
King's College London · Clinic82

Architect of the 82-organ rejuvenation framework; lead doctor, Blueprint.

Clinic82 Clinical Frontier
BJ
Bryan Johnson
Blueprint Protocol

The world's most measured human; open-sourced longevity data.

Referenced for scientific context. No affiliation, endorsement or formal relationship with Clinic82 is implied unless expressly stated — for example, Dr Oliver Zolman.

Sources · Morning Brew, Who's Who in Longevity 2024 · Life Biosciences / Sinclair Lab 2025.

The evidence

What the published science now supports.

Two tiers. Where we act with confidence today, and where we watch the trials before we recommend.

Strongest evidence

Zone 2 & resistance training

The most validated human longevity intervention. Cardiorespiratory fitness predicts lifespan better than cholesterol.

Time-restricted eating

Eight-to-ten hour eating windows reduce metabolic inflammation without strict calorie counting.

Alternative Healthy Eating Index

A diet-quality score built around foods shown to reduce chronic disease outcomes. Higher AHEI scores are inversely associated with all-cause, cardiovascular and cancer mortality across large multi-ethnic cohorts.

Sleep architecture

Restoring deep sleep and REM cycles is among the highest-leverage interventions in the biological ageing literature.

In clinical trials

Rapamycin & Senolytics

Mechanism-of-action approaches to cellular ageing. Rapamycin (mTOR inhibition) confirmed safe in humans in the PEARL trial (2025). Senolytics (dasatinib+quercetin, fisetin) in Phase 2 across multiple age-related diseases. Neither is standard of care.

GLP-1 agonists

Beyond weight loss — reducing cardiovascular disease, chronic inflammation and Alzheimer's risk. Nature Biotechnology's pick for the first true longevity drug.

Epigenetic reprogramming

Yamanaka-factor cocktails reset epigenetic age in tissue; first-in-human trials began in 2026.

Sources · Mannick et al., Lancet Healthy Longevity 2025 · Nature Biotechnology 2025 · Lifespan.io 2025 · George et al., American Journal of Clinical Nutrition, 2014.

Zolman's Longevity Programmes

Add years to your life.
Add life to your years.

Lifespan — how long you live — is a real, measurable target. Healthspan — how many of those years you live well — is the target we intervene on. The Longevity Programmes at Clinic82 are built around measurable improvement in the second, delivered through disciplined intervention on the first.